Skip to navigation Skip to content



Dr. Stephen Hauser, National MS Society Leadership Volunteer, Wins Charcot Award

March 15, 2013

National MS Society leadership volunteer Stephen Hauser, MD, of the University of California, San Francisco, has been selected to receive the prestigious Charcot Award.  The Charcot Award recognizes lifetime achievement in MS research and it is given once every two years by the MS International Federation.

Dr. Hauser is the Robert A. Fishman Distinguished Professor and Chair of the Department of Neurology at UCSF.  He is a long-time friend of the National MS Society. He has served as a volunteer in Greater New England and Northern California chapters and is currently on the national Research Programs Advisory Committee. His stellar career began, in part, with a National MS Society research fellowship, which led to winning the Society's prestigious Harry Weaver Neuroscience Scholar early career award, further cementing his commitment to multiple sclerosis.

Dr. Hauser has been the recipient of a number of Society Research Grants to support his ground-breaking research on the genetic basis of MS.  He joined forces with the Society to establish the MS DNA Bank at UCSF. Many families with MS have donated their genetic material to this resource so that researchers around the world can conduct vital research to understand how a person’s genetic makeup contributes to MS.  Read about how to participate.

In 2008 he won the John Dystel Prize for MS Research, given jointly by the National MS Society and American Academy of Neurology.

In addition to being an outstanding MS researcher, Dr. Hauser has been a mentor to a number of Society Fellows who have gone on to make many important contributions to MS research.

Read more about Dr. Hauser and the Charcot Award

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.